Artificial Intelligence in Endoscopic Ultrasound for Pancreatic Conditions
This study is looking at how well an artificial intelligence (AI) system can find problems in the pancreas during an endoscopic ultrasound (EUS) procedure. An EUS uses a special camera with an ultrasound on the end to look closely at organs like the pancreas. Doctors (endoscopists) already use EUS to diagnose conditions like pancreatic cancer. This study wants to see if the AI system can detect the same abnormalities that an endoscopist finds. The goal is to see if AI could help doctors interpret these images, potentially reducing errors and making it easier to learn how to use EUS. You can join if you are 18 years or older and are already having an EUS examination. The study will measure how many pancreatic abnormalities the AI detects within one day.
- Study design
- This is an observational study involving 310 participants. It is designed to compare what an AI system detects during an endoscopic ultrasound with what a doctor detects.
- What's involved
- You will undergo an endoscopic ultrasound procedure as planned. The study will then compare what the AI platform detects with what your doctor identifies during that procedure.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, the rate of detection of pancreatic abnormalities by AI, is measured at 1 day.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Artificial Intelligence in Endoscopic Ultrasound
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Shyam Varadarajulu, MD · PRINCIPAL_INVESTIGATOR · Orlando Health, Digestive Health Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of detection pancreatic abnormalities by AI1 day
Ability of AI to detect pancreatic abnormalities as identified by an endoscopist during EUS examination of the pancreas.